APOE and neuroenergetics: an emerging paradigm in Alzheimer's disease

作者：Wolf Andrew B; Caselli Richard J; Reiman Eric M; Valla Jon^*

来源：Neurobiology of Aging, 2013, 34(4): 1007-1017.

DOI：10.1016/j.neurobiolaging.2012.10.011

• APOE
• Apolipoprotein E
• Mitochondria
• Neuroenergetics
• Brain imaging
• fMRI
• FDG PET
• Cytochrome oxidase
• Biomarkers
• Alzheimer's disease
• Energy metabolism
• Neurodegeneration

APOE is the major known genetic risk factor for late-onset Alzheimer's disease. Though relationships between APOE-encoded apolipoprotein E and beta-amyloid are increasingly well described, mounting evidence supports wide-ranging effects of APOE on the brain. Specifically, APOE appears to affect brain network activity and closely related neuroenergetic functions that might be involved in vulnerability to neurodegenerative pathophysiology. These effects highlight the salience of further investigation into the diverse influences of APOE. Therefore, this article reviews the interplay between APOE and neuroenergetics and proposes areas for further investigation. This research might lead to the identification of novel therapeutic targets for the treatment and/or prevention of Alzheimer's disease.

• 出版日期2013-4